News & Blog
News & Blog
Biogen Completes Acquisition of Reata Pharmaceuticals
Meet the Community 2: A Closer Look – Tiffany Rose Gambill
Meet the Community – Sam Bridgman
Meet the Community – Lilly Woods
Design Therapeutics Provides Pipeline Update and Reports Second Quarter 2023 Financial Results
Initial Data from Phase 1 Multiple-Ascending Dose Trial of DT-216 for Friedreich Ataxia Showed Significant Increase in FXN mRNA Levels i...
2023 FARA Fellows
The FARA Fellow Program recognizes young investigators who will commit their early career to FA research and want to grow their profile ...
Meet the Community – Robbi Van Schoick
Meet the Community – Duncan Collins
Larimar Therapeutics Receives FDA Clearance
Larimar Therapeutics Receives FDA Clearance to Proceed to 50 mg Cohort in CTI-1601’s Phase 2 Friedreich’s Ataxia Trial and to Initiate Open Label Extension Trial
